(3) Does it matter if we use IL-6, PCT, or CRP as routine markers for early detection of VAP and antibiotic usage? To our knowledge, this is the first study to investigate the role of PCT, CRP, and IL-6 levels, particularly in relation to their effect on clinical outcomes. The gene discussed is CRP; the disease is ventilator-associated pneumonia.